The GTP team will attend the Festival of Biologics on October 15-17, 2019. Do not hesitate to stop by Booth 1 to meet us!
GTP is looking for a Business Developer to grow our business and develop our presence and sales in France and Europe.
The GTP Team would like to wish you a very happy and successful 2019! We’d also like to take advantage of this opportunity to quickly look back on 2018 and lift (a bit of) the veil on what you can look forward to in 2019.
Though not the only key for the success of your biotherapeutic development programme, selecting a good CHO clone is essential to ensuring the subsequent development of an efficient and robust process.
To provide an integrated offer for the preclinical development of biotherapeutics, GTP has added mammalian cell line development services to its portfolio. We can now supply a CHO stable cell line ready for transfer to GMP manufacturing.
Why membrane chromatography may be beneficial to your protein purification process. Why and where you should use membrane chromatography.
Advice from GTP’s experts to help you define and develop the best process for your recombinant protein and antibody project.
What is antibody humanisation and what are the main differences between chimeric, humanised and fully human antibodies? An overview of what we learned from our discussions with Olivier Léger, an expert in antibody engineering with over 25 years' experience in the field.
GTP's BSO assists technical leaders, assesses risks and is key to the implementation and continued application of a full-fledged biosafety policy.
The design, operation and maintenance procedure for low endotoxin levels, of our well adapted and functional but not state-of-the-art purified water distribution loop.